Taxus Element in Diabetics Registry
Overview
TED "Taxus Element in Diabetics Registry" is a multi-country, multi-center, observational, open-label medical registry designed to electronically capture data, manage, monitor, and report in diabetic patients' outcomes receiving Paclitaxel eluting Taxus Element Stent.
TED is designed to be non experimental study, where all enrolled patients should be treated according to the current routine hospital practice and standards of care.
TED patient population are only those patients with diabetes mellitus suitable for drug-eluting stent implantation according to the applicable guidelines on percutaneous coronary interventions.
TED Login
Online Registration
TED support team are ready to assist you in all database related issues. In order to get the right answers you are looking for, please follow this link & report your case. Help me 
TED Study Stent
"The C.E. marked Paclitaxel eluting Taxus Element stent of (Boston Scientific, Natick, Massachusetts)"
Project Description
Diabetes has always adversely affected the outcome of percutaneous coronary intervention (PCI) first angioplasty and then later stenting. Patients with diabetes mellitus are known to have a higher adverse event rate after PCI and stenting compared with those without diabetes. This is mainly due to increased restenosis and subsequent need for repeat revascularization.
Read more
Participated Countries
Five countries from across the Middle-east, North Africa and Asia are participating in TED study:
- Saudi Arabia - United Arab Emirates - Lebanon - Tunisia - Iran - Pakistan
Our Objectives
The primary objective of TED electronic-based registry is to evaluate the outcome of Paclitaxel eluting Taxus Element stent in 750 Patients with diabetes mellitus who are suitable for drug-eluting stent implantation according to the applicable guidelines on percutaneous coronary interventions ..... Read more
Quick Links
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
